Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek(National Cancer Institute), Cihan Oguz(National Institutes of Health), Matthias Seifert(National Cancer Institute), Benjamin Ruf(National Cancer Institute), Yuta Myojin(National Cancer Institute), Kylynda C. Bauer(National Cancer Institute), Patrick Huang(National Cancer Institute), Chi Ma(National Cancer Institute), Marina Villamor-Payà(National Institutes of Health), Francisco Rodríguez-Matos(National Cancer Institute), Marlaine Soliman(National Cancer Institute), Rajiv Trehan(National Cancer Institute), Cecilia Monge(National Cancer Institute), Changqing Xie(National Cancer Institute), David E. Kleiner(National Institutes of Health), Bradford J. Wood(National Institutes of Health), Elliot Levy(National Institutes of Health), Anuradha Budhu(National Institutes of Health), Noémi Kedei(National Cancer Institute), Christian T. Mayer(National Institutes of Health), Xin Wei Wang(National Cancer Institute), Justin Lack(National Institutes of Health), William G. Telford(National Institutes of Health), Firouzeh Korangy(National Cancer Institute), Tim F. Greten(National Cancer Institute)
Cited by 24Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis